| Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection LJ Caverly, M Zimbric, M Azar, K Opron, JJ LiPuma ERJ open research 7 (2), 2021 | 17 | 2021 |
| Distribution and outcomes of infection of Mycobacterium avium complex species in cystic fibrosis M Azar, M Zimbric, K Shedden, LJ Caverly Journal of cystic fibrosis 19 (2), 232-235, 2020 | 16 | 2020 |
| Retrospective analysis of nontuberculous mycobacterial infection and monochloramine disinfection of municipal drinking water in Michigan N Kotlarz, L Raskin, M Zimbric, J Errickson, JJ LiPuma, LJ Caverly Msphere 4 (4), 10.1128/msphere. 00160-19, 2019 | 13 | 2019 |
| Outcomes of cystic fibrosis pulmonary exacerbations treated with antibiotics with activity against anaerobic bacteria LM Castner, M Zimbric, S Cahalan, C Powell, LJ Caverly Journal of Cystic Fibrosis 20 (6), 926-931, 2021 | 9 | 2021 |
| Sputum metabolites associated with nontuberculous mycobacterial infection in cystic fibrosis P Breen, M Zimbric, K Opron, LJ Caverly Msphere 7 (3), e00104-22, 2022 | 8 | 2022 |
| Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation JH Choi, EC Keen, MA Wallace, S Fishbein, J Prusa, M Zimbric, ... The Journal of Infectious Diseases 228 (3), 321-331, 2023 | 2 | 2023 |
| Itaconic acid inhibits nontuberculous mycobacterial growth in pH dependent manner while 4-octyl-itaconic acid enhances THP-1 clearance of nontuberculous mycobacteria in vitro P Breen, M Zimbric, LJ Caverly Plos one 19 (5), e0303516, 2024 | | 2024 |
| 469 Epidemiology and clinical outcomes of airway infection with Pseudomonas species other than P. aeruginosa in cystic fibrosis N Youssef, M Zimbric, L Caverly Journal of Cystic Fibrosis 21, S268, 2022 | | 2022 |
| WS18. 1 Cystic fibrosis airway microbiota associated with outcomes of nontuberculous mycobacterial infection L Caverly, M Zimbric, M Azar, K Opron, J Lipuma Journal of Cystic Fibrosis 19, S30, 2020 | | 2020 |
| DIFFERENCES IN SPUTUM METABOLOME BETWEEN CF PATIENTS WITH AND WITHOUT NONTUBERCULOUS MYCOBACTERIAL INFECTION LJ Caverly, M Zimbric, S Cahalan, J LiPuma PEDIATRIC PULMONOLOGY 54, S305-S306, 2019 | | 2019 |
| DOES TREATMENT OF ANAEROBIC BACTERIA AT THE TIME OF PULMONARY EXACERBATION IMPROVE FEV1 RECOVERY? LM Castner, M Zimbric, S Calahan, C Powell, LJ Caverly PEDIATRIC PULMONOLOGY 54, S423-S424, 2019 | | 2019 |
| Municipal Drinking Water Treatment Practices and Risk of Nontuberculous Mycobacterial Infection L Caverly, N Kotlarz, M Zimbric, J Errickson, L Raskin, JJ LiPuma A106. NTM CLINICAL AND TRANSLATIONAL SCIENCE, A2604-A2604, 2018 | | 2018 |
| AIRWAY MICROBIOTA CHANGES PRECEDING NTM INFECTION DIFFER BY NTM DISEASE STATUS IJ Caverly, M Zimbric, J LiPuma PEDIATRIC PULMONOLOGY 52, S341-S342, 2017 | | 2017 |
